NSGC 2026 has ended. This guide stays up as the record of who was there. Next: NSGC 2027, Nov 7–11, 2027 in Tampa
Ascendis Pharma at NSGC 2026
Nov 10–14, 2026 Baltimore, MD ~2.5k attendees Website
Ascendis Pharma takes part in 1 session at NSGC 2026 in Baltimore, and exhibits at Booth 1055. Ascendis Pharma's breakfast symposium introduces Yuviwel (navepegritide), covering how the medicine works, what its clinical trials showed and how it is dosed. The company develops long-acting treatments for rare endocrine and skeletal conditions, achondroplasia among them.
| Organization | NSGC 2026 Attendance |
|---|---|
Ascendis Pharma Copenhagen, Denmark | |
Biopharmaceutical company developing long-acting treatments for rare endocrine and skeletal conditions, including achondroplasia. | Booth Exhibiting at Booth 1055 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Wed Nov 11 7:45–8:30am Discover Yuviwel® (navepegritide) Introduces Ascendis' Yuviwel (navepegritide), covering how it works, its clinical trial results and how it is dosed. |
Find decision makers at Ascendis Pharma
Tell us what you sell and we’ll find the people at Ascendis Pharma most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the National Society of Genetic Counselors (NSGC). Organization details are derived from NSGC’s published exhibitor list and program, and each organization’s own website. Submit a correction